CLINICAL_TRIALS
research
· 2025-06-04
Clinical Trial Update: Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer [NA]
Summary
Clinical trial investigating immun checkpoint washout in patients with invasive ductal breast cancer; current status is recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Istanbul Training and Research Hospital | Conditions: Breast Cancer Metastatic, Breast Carcinoma | NA | Status: RECRUITING